The Latest Cardiac and Vascular News
Penumbra Inc., the world’s leading thrombectomy company, has secured CE Mark for its SwiftPAC™ neuro embolisation coil, which is part of the Swift™ Coil System and is now commercially available in Europe. Penumbra’s SwiftPAC coils are designed as a soft space-seeking “liquid metal” that conforms to the target vessel for dense […]
Stroke diagnostics innovator Wellumio seeks investors to transform stroke recovery Wellumio is transforming stroke care with portable brain scans to rapidly detect acute stroke that cuts diagnosis time and unlocks treatment in the ‘golden hour’ when every second counts WELLINGTON, New Zealand, September 16, 2025 – Wellumio, a New Zealand-based medical […]
KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation (“TMS”) clinics, and Advanced Behavioral Strategies (ABS).
SOUTHLAKE, Texas & MARSEILLE, France–(BUSINESS WIRE)–Rapid Medical™, a leading developer of active endovascular devices, announces that its DRIVEWIRE™ 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America during a limited commercial launch beginning earlier this year. The company also announced receipt of CE Mark under the […]
Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter’s Trackability, Navigation, and Overall Performance in Stroke Procedures MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly…
Advanced 3D model recreates pathological flow conditions to study underlying cerebrovascular disease mechanisms BUSAN, South Korea, Aug. 19, 2025 /PRNewswire/ — Cerebrovascular diseases, including atherosclerosis and stroke, remain a major global health concern. A common feature of these…
SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, filed a patent infringement lawsuit against Balt USA, LLC (Balt) alleging infringement of five U.S. patents held by Route 92 Medical that […]
TACOMA, Wash., July 31, 2025 /PRNewswire/ — Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast Track designation to RNS60, its lead…
NEW YORK, July 24, 2025 /PRNewswire/ — GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 Clinical Trials of its lead drug Nelonemdaz, has been approved by MFDS – South Korea’s…
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]
